Manila Times Business
Applied Biologics Presents Interim CAMPX Clinical Trial Data at the Symposium on Advanced Wound Care (SAWC) Spring 2026
Interim Findings from Prospective Randomized Controlled Trial of XWRAP® Support Continued Enrollment in Chronic Diabetic Foot Ulcer Study SCOTTSDALE, Ariz., June 10, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for chronic wounds, tissue repair, and degenerative disease, presented interim clinical data from the CAMPX Trial at the Symposium on Advanced Wound Care (SAWC) Spring 2026 meeting. The poster presentation, titled "Interim Anal
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Debut Novel by Susan Price Brings 1970s Newport to Life in Summer Read
1h ago
West Red Lake Gold Announces Results of Annual General Meeting
1h ago
Fennec Announces Results of Annual Meeting
1h ago
Credit Acceptance Announces Appointment of Joe Billante as Chief Financial Officer; Jay Martin to Retire After More Than Two Decades of Service
1h ago